探索疼痛和循环炎症蛋白之间的双向因果关联:孟德尔的随机化研究
Yu Wang1, Wenyu Zhou2, Faqiang Zhang2
1Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Clinical and experimental pharmacology & physiology
|July 5, 2024
概括
这项研究表明,循环的炎症蛋白因果影响多部位慢性疼痛 (MCP) 和特定部位的慢性疼痛 (SSCP). 特定的蛋白质提供保护作用或作为危险因素,指导潜在的治疗策略来治疗疼痛.
科学领域:
- 遗传学和分子生物学
- 免疫学 免疫学 免疫学
- 疼痛医学 医学 疼痛医学
背景情况:
- 慢性疼痛,包括多部位 (MCP) 和特定部位 (SSCP),可能与循环炎症蛋白有关.
- 这些蛋白质与各种慢性疼痛疾病之间的确切因果关系在很大程度上是未知的.
研究的目的:
- 使用孟德尔随机化研究91种循环炎症蛋白与MCP和SSCP之间的潜在因果关系.
- 识别特定的炎症蛋白质,这些蛋白质可能起到保护因素或不同类型慢性疼痛的危险因素的作用.
主要方法:
- 采用了两样双向门德尔随机化 (MR) 分析.
- 分析了91种循环炎症蛋白,MCP和SSCP (包括头痛,背部,肩膀,部,膝盖,腹部和面部疼痛) 的数据.
- 逆方差权衡是主要的MR方法,辅以灵敏度分析 (加权中位数,MR-PRESSO,埃格尔截取) 和异质性测试 (科克兰的Q,留出一个).
主要成果:
- 在29种循环炎症蛋白和慢性疼痛疾病之间建立了因果关系.
- 14种蛋白质表现出对MCP和SSCP的保护作用,而15种蛋白质被确定为危险因素.
- 重要的是,MCP和SSCP对循环炎症蛋白水平没有显著的因果影响.
结论:
- 特定的循环炎症蛋白对MCP和SSCP的发展和进展有因果影响.
- 这些发现突出了管理慢性疼痛疾病的潜在治疗目标.
- 这项研究为开发通过调节炎性蛋白质通路的新疗法提供了基础.
相关概念视频
01:44Nociception
27.8K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:25Analgesia and Pain Management
568
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
568